Achieve Commercial Excellence with Harmonized Global Market Intelligence

IQVIA MIDAS® has long been considered the industry benchmark for global market measurement, integrating the breadth and depth of IQVIA's unparalleled data assets with advanced analytics and deep domain expertise across 95 countries.

The newly launched MIDAS Patient adds patient insights across 600 diseases at scale supporting the industry shift towards multi-indication drugs and patient-centricity.

With IQVIA Global Market Insights (GMI) Agent, powered by agentic AI, these insights are now accessible in minutes, enabling faster and smarter decision-making.

In this thought-provoking session, we'll examine key global market trends through patient numbers, revealing surprising trends. For example, while respiratory treatments rank 4th in volume, they lead the way in terms of patient numbers (taking prescription medicines). Through a demonstration of MIDAS Patient, we'll showcase how these patient-centric insights can drive strategic decision-making across the pharmaceutical industry.

Don't miss this opportunity to discover how cutting-edge patient analytics are transforming market analysis, offering a more comprehensive view of the evolving pharmaceutical landscape. Amplify your market understanding to gain a decisive advantage in navigating complex markets.